Avalo Therapeutics, Inc. (AVTX): 8-K filed Nov 5, 2026

Form type

8-K

Filing date

Nov 5, 2026

Accession number

0001104659-26-123079

Filer

Avalo Therapeutics, Inc. (CIK 1534120)